<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-10-20T14:41:55.634Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-10-20T14:41:55.634Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-10-20T14:41:55.634Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-10-20T14:41:55.634Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-10-20T14:41:55.634Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PRSO:1792507230616</loc>
    <lastmod>2026-10-20T14:40:30.616Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PRSO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Peraso shares are trading higher after the company announced the receipt of a production order valued in excess of $2 million for deployment of FWA systems utilizing Peraso&amp;#39;s 60 GHz technology.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BIIB:1792507032420</loc>
    <lastmod>2026-10-20T14:37:12.420Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BIIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Biogen shares are trading higher after Wells Fargo maintained its Overweight rating on the stock and raised its price target from $250 to $310.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/EWW:1792507024310</loc>
    <lastmod>2026-10-20T14:37:04.310Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EWW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mexico President Claudia Sheinbaum Says Trade Deal With U.S. Is Very Close, Although There Are Still Some Issues To Be Resolved</image:title>
      <image:caption>Mexico President Claudia Sheinbaum announced that a trade deal with the United States is nearing completion, although some issues remain unresolved. This development could have significant implications for trade relations between the two countries. The stock ticker associated with this news is EWW.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FRTT:1792506992045</loc>
    <lastmod>2026-10-20T14:36:32.045Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FRTT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Fort Technology shares are trading higher after the company announced its majority-owned subsidiary Logia USA has entered into an exclusive Commercial Distributorship Agreement with Schwab Vollhaber Lubratt.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BA:1792506779802</loc>
    <lastmod>2026-10-20T14:32:59.802Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/The-Boeing-Company.jpg?width=250&amp;height=187</image:loc>
      <image:title>Six Years Late, Boeing&amp;#39;s Biggest 737 MAX May Finally Be Cleared for Takeoff</image:title>
      <image:caption>Boeing Co. is set to receive FAA certification for its delayed 737 MAX 10 aircraft, with an announcement expected from U.S. Transportation Secretary Sean Duffy. The MAX 10, which can seat up to 230 passengers, has nearly 1,500 orders, representing about 30% of Boeing&#39;s 737 backlog. Boeing&#39;s stock fell 0.34% to $190.76 as investors await the company&#39;s third-quarter earnings report, which is projected to show a loss of 19 cents per share and revenue growth to $24.42 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FRNM:1792506716786</loc>
    <lastmod>2026-10-20T14:31:56.786Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FRNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Freenome shares are trading higher after the company announced the launch of SimpleScreen Lung and a first-of-its-kind offering that enables eligible patients to be screened for both lung and colorectal cancer through a single blood draw.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CON:1792506262417</loc>
    <lastmod>2026-10-20T14:24:22.417Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CON/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Stephens &amp;amp; Co. Initiates Coverage On Concentra Group Holdings with Overweight Rating, Announces Price Target of $45</image:title>
      <image:caption>Stephens &amp; Co. has initiated coverage on Concentra Group Holdings (NYSE: CON) with an Overweight rating. The firm has set a price target of $45 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ATNM:1792506172863</loc>
    <lastmod>2026-10-20T14:22:52.863Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ATNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Actinium shares are trading higher after the company announced preclinical results demonstrating broad antitumor potential of ATNM-400 across non-small cell lung, colorectal and ovarian cancer models, along with initial Phase 1 clinical results in metastatic castration-resistant prostate cancer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CRWV:1792506044409</loc>
    <lastmod>2026-10-20T14:20:44.409Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HSBC Reiterates Reduce on CoreWeave, Maintains $39 Price Target</image:title>
      <image:caption>HSBC analyst Abhishek Shukla has reiterated a &#39;Reduce&#39; rating on CoreWeave (NASDAQ: CRWV) while maintaining a price target of $39. This indicates a cautious outlook on the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/KRMN:1792506021046</loc>
    <lastmod>2026-10-20T14:20:21.046Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Karman shares are trading higher after the company announced it entered into a seven-year, $218 million agreement with Lockheed Martin to provide shrouds for the Terminal High Altitude Area Defense program.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RVMD:1792505994531</loc>
    <lastmod>2026-10-20T14:19:54.531Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Revolution Medicine shares are trading higher. The company announced that it has begun treating patients in its Phase 3 clinical trial of zoldonrasib in combination with pembrolizumab plus chemotherapy to treat metastatic non-squamous non-small cell lung cancer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RCUS:1792505932457</loc>
    <lastmod>2026-10-20T14:18:52.457Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RCUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Arcus Biosciences shares are trading higher after the company announced new data from the ARC-20 platform study evaluating casdatifan, an investigational next-generation HIF-2α inhibitor, alone or in combination, as a first-, second-, and late-line treatment for clear cell renal cell carcinoma.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RVMD:1792505815866</loc>
    <lastmod>2026-10-20T14:16:55.866Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Revolution Medicine shares are trading higher. The company announced that it has begun treating patients in its Phase 3 clinical trial of zoldonrasib in combination with pembrolizumab plus chemotherapy to treat metastatic non-squamous non-small cell lung cancer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HAS:1792505786710</loc>
    <lastmod>2026-10-20T14:16:26.710Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Hasbro.jpg?width=250&amp;height=187</image:loc>
      <image:title>Hasbro Posts Upbeat Q3 Earnings, Joins Myriad Genetics, Equifax And Other Big Stocks Moving Higher On Tuesday</image:title>
      <image:caption>Hasbro Inc (NASDAQ: HAS) reported strong third-quarter earnings with adjusted earnings of $2.90 per share, surpassing the analyst consensus estimate of $1.86. Revenue increased by 15% year-over-year to $1.595 billion, exceeding expectations of $1.476 billion. Following the announcement, Hasbro&#39;s shares rose 6.2% to $104.64, and the company also raised its outlook for 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/KMB:1792505778021</loc>
    <lastmod>2026-10-20T14:16:18.021Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>China Unconditionally Approves Kimberly-Clark’s Acquisition Of Kenvue On October 10, 2026, Clearing Key Antitrust Hurdle</image:title>
      <image:caption>On October 10, 2026, China&#39;s regulatory authority granted unconditional approval for Kimberly-Clark&#39;s acquisition of Kenvue, overcoming a significant antitrust hurdle. This approval is expected to facilitate Kimberly-Clark&#39;s strategic expansion in the consumer health sector. The acquisition is likely to impact Kimberly-Clark&#39;s market position and financial performance positively.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NNVC:1792505543990</loc>
    <lastmod>2026-10-20T14:12:23.990Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNVC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NanoViricides shares are trading higher after the company announced its broad-spectrum antiviral drug NV-387 has demonstrated strong safety, tolerability, and toxicological parameters in an animal model study involving juvenile mouse pups.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SPOT:1792505538467</loc>
    <lastmod>2026-10-20T14:12:18.467Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPOT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Believe And Spotify Partner To Unlock New Opportunities For Artists Through Licensed Fan Remixes And Covers</image:title>
      <image:caption>Believe and Spotify have entered into a licensing agreement aimed at enabling artists to create and monetize fan-made remixes and covers. This partnership is expected to unlock new revenue streams for artists and enhance fan engagement on the Spotify platform. The collaboration highlights Spotify&#39;s commitment to supporting artist creativity and expanding its content offerings.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/UNH:1792505427546</loc>
    <lastmod>2026-10-20T14:10:27.546Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UnitedHealth Group shares are trading higher amid a rally sparked sparked by the company&amp;#39;s better-than-expected Q3 financial results on October 13. Also, RBC Capital maintained its Outperform rating on the stock and raised its price target from $478 to $498.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ZTS:1792505399113</loc>
    <lastmod>2026-10-20T14:09:59.113Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs</image:title>
      <image:caption>The FDA has approved a ready-to-use injectable formulation of cefovecin for the treatment of certain skin infections in dogs. This approval is expected to enhance the treatment options available for veterinarians and improve animal health outcomes. The stock ticker for the company associated with this product is ZTS.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RCL:1792505397898</loc>
    <lastmod>2026-10-20T14:09:57.898Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TD Cowen Maintains Buy on Royal Caribbean Group, Raises Price Target to $340</image:title>
      <image:caption>TD Cowen analyst Tom Fitzgerald has maintained a &#39;Buy&#39; rating on Royal Caribbean Group (NYSE: RCL) and raised the price target from $337 to $340. This adjustment reflects confidence in the company&#39;s performance and market position.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BTCUSD:1792505390011</loc>
    <lastmod>2026-10-20T14:09:50.011Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Bitcoin-Btc-Virtual-Cryptocurrency-In-Fr.jpg?width=250&amp;height=187</image:loc>
      <image:title>Bitcoin Hits $82,000 as Whales Accumulate: Is the Bottom in?</image:title>
      <image:caption>Bitcoin (BTC) reached $82,000 on Tuesday morning, despite a 6% drop from its early October high. It is currently holding above critical support at $80,400, indicating a correction rather than a sustained downtrend, although the futures market remains unfavorable for buyers. Notably, large Bitcoin holders are shifting towards accumulation, with wallets holding 1,000–10,000 BTC showing a net accumulation improvement from negative 62,600 BTC to positive 5,230 BTC. However, U.S. spot demand remains weak, as indicated by a negative Coinbase Premium Index and recent buyers realizing modest losses.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ADRX:1792505167885</loc>
    <lastmod>2026-10-20T14:06:07.885Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ADRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating</image:title>
      <image:caption>TD Cowen analyst Tyler Van Buren has initiated coverage on Adarx Pharmaceuticals (NASDAQ: ADRX) with a Buy rating. This marks a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BLK:1792505050083</loc>
    <lastmod>2026-10-20T14:04:10.083Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BLK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TD Cowen Upgrades BlackRock to Buy, Raises Price Target to $1405</image:title>
      <image:caption>TD Cowen analyst Bill Katz has upgraded BlackRock (NYSE: BLK) from a &#39;Hold&#39; rating to &#39;Buy&#39; and increased the price target from $1212 to $1405. This upgrade reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CLF:1792504915001</loc>
    <lastmod>2026-10-20T14:01:55.001Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLF/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $17</image:title>
      <image:caption>Wells Fargo analyst Timna Tanners has maintained an Overweight rating on Cleveland-Cliffs (NYSE: CLF) and raised the price target from $14 to $17. This adjustment reflects an optimistic outlook for the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SPY:1792504809745</loc>
    <lastmod>2026-10-20T14:00:09.745Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>USA Pending Home Sales (MoM)  September -7.3% Vs -0.7% Est.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NU:1792504807357</loc>
    <lastmod>2026-10-20T14:00:07.357Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nu Holdings shares are trading higher after UBS maintained its Buy rating on the stock and raised its price target from $18.2 to $20.5.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MMM:1792504607414</loc>
    <lastmod>2026-10-20T13:56:47.414Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MMM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>3M shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY26 adjusted EPS guidance above estimates.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BIIB:1792504547541</loc>
    <lastmod>2026-10-20T13:55:47.541Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BIIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Maintains Overweight on Biogen, Raises Price Target to $310</image:title>
      <image:caption>Wells Fargo analyst Mohit Bansal has maintained an Overweight rating on Biogen (NASDAQ: BIIB) and increased the price target from $250 to $310. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IRON:1792504440469</loc>
    <lastmod>2026-10-20T13:54:00.469Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $124</image:title>
      <image:caption>Wells Fargo analyst Derek Archila has maintained an Overweight rating on Disc Medicine (NASDAQ: IRON) and increased the price target from $86 to $124. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GE:1792504430103</loc>
    <lastmod>2026-10-20T13:53:50.103Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Tallinn--Estonia---August-4th-2023---Scr.jpg?width=250&amp;height=187</image:loc>
      <image:title>Dow Gains Over 200 Points; GE Aerospace Posts Upbeat Earnings</image:title>
      <image:caption>The Dow Jones index rose by over 200 points, closing up 0.43% at 52,187.83, while the NASDAQ and S&amp;P 500 fell by 0.86% and 0.24%, respectively. GE Aerospace reported third-quarter earnings of $2.25 per share, exceeding the analyst estimate of $2.00, with quarterly sales of $14.118 billion, surpassing the forecast of $12.849 billion. Additionally, the company raised its FY2026 earnings forecast.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AAPL:1792504180587</loc>
    <lastmod>2026-10-20T13:49:40.587Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Basel--Switzerland---December-23--2024-A.jpg?width=250&amp;height=187</image:loc>
      <image:title>Apple Stock in Focus as iPhone Duo Launch, U.S. Expansion and Earnings Loom</image:title>
      <image:caption>Apple Inc. (NASDAQ: AAPL) is preparing for the launch of the iPhone Duo on October 23, with pre-orders having sold out quickly. The company has announced new U.S. manufacturing partnerships, committing up to $100 million over three years, as part of a $600 billion U.S. investment plan. Analysts estimate earnings per share of $1.98 on revenue of $113.07 billion for the upcoming fiscal fourth-quarter results on November 2, while Apple shares are currently trading 0.62% lower at $340.83.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PBAM:1792504072907</loc>
    <lastmod>2026-10-20T13:47:52.907Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PBAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Piper Sandler Maintains Overweight on Private Bancorp, Raises Price Target to $101</image:title>
      <image:caption>Piper Sandler analyst Matthew Clark has maintained an Overweight rating on Private Bancorp (NASDAQ: PBAM) and increased the price target from $96 to $101. This adjustment reflects positive expectations for the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GE:1792503832622</loc>
    <lastmod>2026-10-20T13:43:52.622Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GE Aerospace shares are trading lower after the company reported Q3 financial results. During a conference call, the company&amp;#39;s CFO mentioned growing spare parts delinquency and that investors should assume fewer GE9X units for 2026.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HAL:1792503828055</loc>
    <lastmod>2026-10-20T13:43:48.055Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halliburton Expects Completion And Production Margins To Improve 75 To 125 Basis Points Sequentially</image:title>
      <image:caption>Halliburton anticipates an improvement in completion and production margins by 75 to 125 basis points sequentially. This expectation reflects the company&#39;s ongoing efforts to enhance operational efficiency and profitability. The stock ticker for Halliburton is HAL.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MMM:1792503557934</loc>
    <lastmod>2026-10-20T13:39:17.934Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MMM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>3M CEO Says Expanded Beam Optics Sales Could Likely Double Next Year</image:title>
      <image:caption>3M&#39;s CEO announced during a recent conference call that sales of the company&#39;s expanded beam optics are expected to potentially double in the next year. This projection indicates a significant growth opportunity for the company in this product segment. The announcement may positively influence investor sentiment and stock performance for 3M (MMM).</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SATS:1792503519807</loc>
    <lastmod>2026-10-20T13:38:39.807Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SATS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Strive Closes Upsized $630M IPO Of 15% Series A Perpetual SATS Preferred Stock At $90/Share; Shares Expected To Begin Trading On Nasdaq Global Market Around October 20, 2026, Under Ticker &amp;#39;SATS&amp;#39;</image:title>
      <image:caption>Strive, Inc. has successfully closed its upsized initial public offering of 7,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock at a price of $90 per share, totaling $630 million. The SATS Stock is set to begin trading on the Nasdaq Global Market under the ticker &#39;SATS&#39; around October 20, 2026. The SATS Stock will accumulate cumulative dividends at a rate of 15.00% per annum, with the first scheduled regular dividend expected to be paid on November 9, 2026, if declared in full.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FXI:1792503405290</loc>
    <lastmod>2026-10-20T13:36:45.290Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FXI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>China&amp;#39;s Commerce Ministry, On U.S. Order On DeepSeek, Says China Firmly Opposes This; U.S. Move Discriminatory, Politicizes Tech And Trade Issues Under Guise Of National Security; U.S. Action Disregards Consensus Reached Between Chinese, U.S. Heads Of State; Urges U.S. To Immediately Correct Wrong Practices, Revoke Discriminatory Restrictions On Chinese Firms</image:title>
      <image:caption>China&#39;s Commerce Ministry has expressed strong opposition to a recent U.S. order affecting the Chinese firm DeepSeek, labeling it as discriminatory and politicizing technology and trade under the pretext of national security. The Ministry criticized the U.S. for disregarding agreements made between the leaders of China and the U.S. and urged the U.S. to rectify its actions and lift restrictions on Chinese companies.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VSXY:1792503366696</loc>
    <lastmod>2026-10-20T13:36:06.696Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VSXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barclays Maintains Overweight on Victoria&amp;#39;s Secret, Raises Price Target to $112</image:title>
      <image:caption>Barclays analyst Adrienne Yih has maintained an Overweight rating on Victoria&#39;s Secret (NYSE: VSXY) and increased the price target from $106 to $112. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NOC:1792503361259</loc>
    <lastmod>2026-10-20T13:36:01.259Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Northrop Grumman shares are trading higher after the company reported better-than-expected Q3 EPS results and raised its FY26 adjusted EPS guidance above estimates.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IREN:1792503310507</loc>
    <lastmod>2026-10-20T13:35:10.507Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/IREN.jpg?width=250&amp;height=187</image:loc>
      <image:title>What&amp;#39;s Going On With IREN Stock Tuesday?</image:title>
      <image:caption>IREN Ltd. (NASDAQ: IREN) stock fell 3.57% to $26.74 in premarket trading on Tuesday, driven by concerns over AI infrastructure debt and rising financing costs, contributing to a nearly 4% decline. The stock is currently 53.17% lower than it was a year ago and remains below key moving averages, indicating a bearish trend. Analysts maintain a consensus Buy rating with an average price target of $77.33, despite recent downgrades in price forecasts by some firms. Investors are closely monitoring support levels around $26.55 as the stock approaches its 52-week low.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XCH:1792503263031</loc>
    <lastmod>2026-10-20T13:34:23.031Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>XCHG Shares Halted On Circuit Breaker To The Upside, Stock Now Up 41.38%</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XHG:1792503238561</loc>
    <lastmod>2026-10-20T13:33:58.561Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XHG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 12.5%</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/UNH:1792503213350</loc>
    <lastmod>2026-10-20T13:33:33.350Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/UNH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on UnitedHealth Group, Raises Price Target to $498</image:title>
      <image:caption>RBC Capital analyst Ben Hendrix has maintained an Outperform rating on UnitedHealth Group (NYSE: UNH) and raised the price target from $478 to $498. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/INTU:1792503160374</loc>
    <lastmod>2026-10-20T13:32:40.374Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INTU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Intuit Launches Credit Karma Tax With $0 Federal Filing, Flat-Rate $15 State Returns</image:title>
      <image:caption>Intuit Inc. has launched Credit Karma Tax, offering $0 federal filing and a flat-rate $15 for state returns, regardless of tax complexity. The service provides AI-powered support throughout the tax filing process and aims to deliver refunds up to five days earlier for free. This initiative is part of Intuit&#39;s strategy to enhance financial confidence and simplify tax filing for its members.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HAL:1792503146758</loc>
    <lastmod>2026-10-20T13:32:26.758Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halliburton Expects Middle East Revenue To Grow Both Sequentially And Year Over Year</image:title>
      <image:caption>Halliburton (HAL) anticipates revenue growth in the Middle East, expecting increases both sequentially and year-over-year. The company&#39;s positive outlook reflects strong demand in the region&#39;s oil and gas sector. Specific financial figures or growth percentages were not provided in the article.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/RAPP:1792503077747</loc>
    <lastmod>2026-10-20T13:31:17.747Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Doctor-Holding-Virtual-Brain-Representin.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Rapport Therapeutics Stock Trading Higher Today?</image:title>
      <image:caption>Rapport Therapeutics Inc. (NASDAQ: RAPP) stock rose 36.02% to $38.90 in premarket trading, with a volume of 1.439 million shares compared to the average of 351.078 thousand. The increase follows the announcement of positive topline results from a Phase 2 clinical trial of RAP-219, which achieved its primary endpoint in treating acute bipolar mania. The trial demonstrated a statistically significant improvement in manic symptoms, and the company plans to engage with the FDA for Phase 3 trials in 2027, supported by $436.1 million in cash equivalents.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MTGG:1792503002830</loc>
    <lastmod>2026-10-20T13:30:02.830Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MTGG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trading Halt: Halt status updated at 9:30:00 AM ET: Quotation Resumption: IPO security released for quotation</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HCTI:1792502981515</loc>
    <lastmod>2026-10-20T13:29:41.515Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HCTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Healthcare Triangle Expects Annual Revenue Of ~$1.34M By Its Teyame Business; Teyame Also Intends To Sign Additional ~$3.31M Engagements In Incremental Annual Revenue Beginning January Next Year</image:title>
      <image:caption>Healthcare Triangle, Inc. (Nasdaq: HCTI) announced that its Teyame business has signed six client engagements expected to generate approximately $1.34 million in annual revenue, with services commencing in late 2026. Additionally, Teyame aims to secure another engagement that could contribute about $3.31 million in incremental annual revenue starting January 2027. If all engagements reach their projected run rates, total revenue could amount to approximately $4.65 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GLXY:1792502866721</loc>
    <lastmod>2026-10-20T13:27:46.721Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/20/Coins-On-Black-Background---Litecoin--Bi.jpg?width=250&amp;height=187</image:loc>
      <image:title>Citi Upgrades Galaxy, Gemini, Names Circle, Bullish as Top Crypto Picks</image:title>
      <image:caption>Citi upgraded its ratings for Galaxy (NYSE: GLXY) and Gemini (NASDAQ: GEMI) while naming Circle (NYSE: CRCL) and Bullish (NYSE: BLSH) as its top cryptocurrency equity picks ahead of Q3 earnings. The bank set a price target of $243 for Circle, citing its compliant platform, strong liquidity position, and the potential of its Arc settlement network. Conversely, Citi downgraded Securitize due to concerns over short-term supply pressure and uncertainty regarding the evolution of unit economics in tokenization services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NNN:1792502803285</loc>
    <lastmod>2026-10-20T13:26:43.285Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Barclays Maintains Underweight on NNN REIT, Lowers Price Target to $43</image:title>
      <image:caption>Barclays analyst Richard Hightower has maintained an Underweight rating on NNN REIT (NYSE: NNN) and has reduced the price target from $47 to $43.</image:caption>
    </image:image>
  </url>
</urlset>